Biggest News Aggregation in the World
📰 Prostate News

Page 117 - Prostate News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Prostate. Real-time updates on events, politics, business and more.

Combination of three drugs extends the survival of patients with metastatic, hormone-sensitive prostate cancer

Results from an international, randomized, double-blind, placebo-controlled, phase 3 clinical trial indicate that adding the androgen-receptor inhibitor darolutamide to androgen-deprivation therapy and chemotherapy prolongs the survival of men with metastatic, hormone-sensitive prostate cancer, a disease that is fatal in most cases.
United States Emily Henderson Matthewr Smith Genitourinary Oncology Program Cancer Center Harvard Medical School

Exercise program offers psychological benefits during active surveillance for prostate cancer

In men undergoing active surveillance as an alternative to immediate treatment for prostate cancer, a supervised exercise program can reduce anxiety and fear of cancer progression, reports a study in The Journal of Urology, an Official Journal of the American Urological Association.
United States Dana Farber Cancer Institute Kerrys Courneya Emily Henderson University Of Alberta Wolters Kluwer

Modra Pharmaceuticals Presents Positive Phase IIb Results for ModraDoc006/r, a Boosted Oral Taxane for Patients with Metastatic Prostate Cancer, at 2022 ASCO GU Annual Meeting

Results support ModraDoc006/r as an effective, convenient, and well tolerated oral docetaxel treatment option for patients with mCRPC Response rates compare favorably to intravenous (IV) docetaxel
United States Kostenloser Wertpapierhandel Colin Freund Ulka Vaishampayan Desmond James Modra Pharmaceuticals

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Orion Oyj: Darolutamide plus androgen deprivation therapy and docetaxel significantly increases overall survival in patients with metastatic hormone-sensitive prostate cancer

ORION CORPORATION PRESS RELEASE17 FEBRUARY 2022 at 23.32 EET Darolutamide plus androgen deprivation therapy and docetaxel significantly increases overall survival in patients with
Eteläuomen Läi Tuukka Hirvonen Orion Corporation Investor Relations Cancer Statistics Mortality Worldwide

Most online prostate cancer content lacks Black and Latinx representation, study reports

Despite their higher risks of advanced prostate cancer, Black and Latinx men are under-represented on websites and in online videos providing information and education regarding prostate cancer, reports a study in The Journal of Urology, an official journal of the American Urological Association.
United States Stacy Loeb Emily Henderson York University Langone Health Wolters Kluwer American Urological Association

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science